Evidence map›Paper›PMID 33557209›Full record

ArticleAntibiotics (Basel, Switzerland)2021

First Report of an Extensively Drug-Resistant ST23

Marta Hernández, Luis López-Urrutia, David Abad, Mónica De Frutos Serna, Alain A Ocampo-Sosa, José María Eiros

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pathogens (Basel, Switzerland) · 2024
    Pooled it
  2. Article
  3. TRAIL-mediated armA upregulation enhances the drug resistance ofAmerican journal of translational research · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Screening ofAntibiotics (Basel, Switzerland) · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Bacteriological characteristics of hypervirulentIranian journal of microbiology · 2022
    Article
  12. Article
  13. Article
  14. Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2021
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Marta HernándezLaboratorio de Biología Molecular y Microbiología, Instituto Tecnológico Agrario de Castilla y León (ITACyL), 47071 Valladolid, Spain.ORCID 0000-0001-6914-9987
Luis López-UrrutiaServicio de Microbiología, Hospital Universitario del Río Hortega, 47012 Valladolid, Spain.ORCID 0000-0002-8128-0993
David AbadLaboratorio de Biología Molecular y Microbiología, Instituto Tecnológico Agrario de Castilla y León (ITACyL), 47071 Valladolid, Spain.ORCID 0000-0001-5423-3537
Mónica De Frutos SernaServicio de Microbiología, Hospital Universitario del Río Hortega, 47012 Valladolid, Spain.ORCID 0000-0001-6291-0622
Alain A Ocampo-SosaLaboratorio de Microbiología Clínica y Molecular, Instituto de Investigación Sanitaria Marqués de Valdecilla (IDIVAL), 39011 Santander, Spain.ORCID 0000-0002-9104-3115
José María EirosServicio de Microbiología, Hospital Universitario del Río Hortega, 47012 Valladolid, Spain.
Hospital Universitario Río Hortega · ESInstituto Tecnológico Agrario de Castilla y León · ESInstituto de Investigación Marqués de Valdecilla · ES

Funding

Junta de Castilla y León GRS1780/A/18Spanish Ministry of Economy and Competitiveness (MINECO) AGL2016-74882-C3
6 · The paper itself

Abstract

An extensively drug-resistant (XDR)

Indexed as

ArmACTX-M-15extensively drug-resistanthybrid virulence/resistance plasmidshypervirulent Klebsiella pneumoniaeKlebsiella pneumoniaeOXA-48

Identifiers

PMID33557209
PMCPMC7913926
OpenAlexW3126372778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.